PRESS RELEASE published on 01/23/2026 at 08:00, 7 months 27 days ago Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF published on 11/27/2025 at 00:20, 9 months 22 days ago Transgene: Resumption of Trading on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/27/2025 at 00:15, 9 months 22 days ago Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets Transgene resumes trading of shares on Euronext Paris following capital increase results publication Euronext Paris Shares Trading Capital Increase Transgene
BRIEF published on 11/26/2025 at 23:37, 9 months 23 days ago Transgene Raises €105 Million for Cancer Vaccine Development Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE published on 11/26/2025 at 23:32, 9 months 23 days ago Transgene Successfully Completes a Fundraising of c. €105 Million Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028 Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
BRIEF published on 11/25/2025 at 22:06, 9 months 24 days ago Transgene raises funds with the Talisman project Euronext Paris Fundraising Transgene Talisman Myvac®
BRIEF published on 11/25/2025 at 21:47, 9 months 24 days ago Temporary suspension of trading in Transgene shares Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/25/2025 at 21:42, 9 months 24 days ago Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results. Trading to resume on November 27, 2025 Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 20:46, 9 months 24 days ago Temporary Suspension of Trading in Transgene Shares on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Trading Suspended
PRESS RELEASE published on 11/25/2025 at 20:41, 9 months 24 days ago Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results Euronext Paris Trading Capital Increase Suspension Transgene
Published on 09/19/2026 at 00:55, 22 hours 53 minutes ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 23 hours 58 minutes ago Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 1 day 1 hour ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 3 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 1 day 9 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/19/2026 at 16:40, 7 hours 8 minutes ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/19/2026 at 13:15, 10 hours 33 minutes ago Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO
Published on 09/19/2026 at 07:30, 16 hours 18 minutes ago Hong Kong sets out initiatives to secure long-term development of pillar industries
Published on 09/18/2026 at 18:44, 1 day 5 hours ago EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:34, 1 day 5 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 2 days 6 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
